MONITORING UTILIZATION TRENDS OF GLUCOSE-LOWERING DRUGS FOR TYPE 2 DIABETES IN OLDER ADULTS BY FRAILTY STATUS

被引：0
|
作者：
Gopalakrishnan, Chandrasekar [1 ,2 ]
Kim, Dae [3 ]
Kutz, Alexander [4 ]
Patorno, Elisabetta [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Hebrew SeniorLife, Boston, MA USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
来源：
INNOVATION IN AGING | 2021年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：208 / 208
页数：1
相关论文
共 50 条
  • [41] Cardiovascular outcome trials of glucose-lowering drugs in type 2 diabetes: 10 frequently asked questions
    George, Jyothis T.
    PRACTICAL DIABETES, 2015, 32 (08) : 301 - 304
  • [42] Glucose-lowering drugs and heart failure: implications of recent cardiovascular outcome trials in type 2 diabetes
    Cattadori, Gaia
    Pantanetti, Paola
    Ambrosio, Giuseppe
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 157
  • [43] Mechanisms of glucose-lowering effect by rosiglitazone in patients with type 2 diabetes
    Miyazaki, Y
    Matsuda, M
    Mahankali, A
    Mahankali, S
    Cusi, K
    Mandarino, L
    Defronzo, R
    DIABETES, 2001, 50 : A126 - A127
  • [44] Glucose-lowering therapies in type 2 diabetes: Opportunities and challenges for peptides
    Bailey, Clifford J.
    PEPTIDES, 2018, 100 : 9 - 17
  • [45] Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes
    Yudkin, John S.
    Vijan, Sandeep
    Sussman, Jeremy B.
    Lehman, Richard
    Goldacre, Ben M.
    LANCET, 2014, 384 (9948): : 1095 - 1095
  • [46] INFLUENCE OF GLUCOSE-LOWERING STRATEGIES ON FRACTURE RISK IN TYPE 2 DIABETES
    Gusova, A. A.
    Pavlova, M. G.
    Melnitchenko, G. A.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S160 - S161
  • [47] Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study
    Bongaerts, Brenda
    Arnold, Suzanne, V
    Charbonnel, Bernard H.
    Chen, Hungta
    Cooper, Andrew
    Fenici, Peter
    Gomes, Marilia
    Ji, Linong
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Medina, Jesus
    Nicolucci, Antonio
    Shestakova, Marina
    Shimomura, Iichiro
    Tang, Fengming
    Watada, Hirotaka
    Rathmann, Wolfgang
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [48] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    C. J. Currie
    C. D. Poole
    E. A. M. Gale
    Diabetologia, 2009, 52 : 1766 - 1777
  • [49] Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases
    Prattichizzo, Francesco
    La Sala, Lucia
    Ryden, Lars
    Marx, Nikolaus
    Ferrini, Marc
    Valensi, Paul
    Ceriello, Antonio
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (2_SUPPL) : 73 - 80
  • [50] Impact of glucose-lowering therapies on risk of stroke in type 2 diabetes
    Bonnet, F.
    Scheen, A. J.
    DIABETES & METABOLISM, 2017, 43 (04) : 299 - 313
12345